D 2785
Alternative Names: D-Threo-methylphenidateLatest Information Update: 29 Mar 2000
At a glance
- Originator Celltech Group
- Class Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Attention-deficit hyperactivity disorder
Most Recent Events
- 29 Mar 2000 Discontinued-III for Attention-deficit hyperactivity disorder in United Kingdom (Unknown route)
- 02 Feb 2000 Medeva has been merged into Celltech Chiroscience, which is now called Celltech Group
- 21 Oct 1999 Chiroscience has merged with Celltech to form Celltech Chiroscience